Cutaneous TUBERCLOSIS : 1 M.Yousry TB&leprosy Cutaneous TUBERCLOSIS BY
M.Yousry M.Abdel-Mawla.
Zagazig faculty OF MEDICINE
Cutaneous T B : M.Yousry TB&leprosy 2 Cutaneous T B Mycobacterium tuberculosis is the causative agent of tuberculosis (TB).
Aerobic, nonsporeforming, nonmotile, facultative, intracellular, curved rods measuring 0.2-0.5 by 2.0-4.0 mm.
Stained with acid-fast stain.
The variants of cutaneous TB : M.Yousry TB&leprosy 3 The variants of cutaneous TB Primary-inoculation TB (tuberculous chancre)
TB verrucosa cutis
Scrofuloderma
Lupus vulgaris
TB cutis orificialis
Miliary TB of the skin
Tuberculids
Tuberculous Chancre : M.Yousry TB&leprosy 4 Tuberculous Chancre Results from direct introduction of mycobacteria into the skin or mucosa of an individual who was not previously infected with TB.
. An inflammatory papule develops in 2-4 weeks at the inoculation site that breaks down into a firm, nonhealing, shallow, nontender, undermined ulcer with a granulomatous base. Painless regional lymphadenopathy is evident at 3-8 weeks.
TB verrucosa cutis : M.Yousry TB&leprosy 5 TB verrucosa cutis Occurs after direct inoculation of TB into the skin in someone who has been previously infected with mycobacteria
Presents as a purplish or brownish-red warty growth
Lesions most often occur on the knees, elbows, hands, feet and buttocks
Lesions may persist for years but can clear up even without treatment
Lupus vulgaris : M.Yousry TB&leprosy 6 Lupus vulgaris Persistent and progressive form of cutaneous TB
Small sharply defined reddish-brown lesions with a gelatinous consistency (called apple-jelly nodules)
Lesions persist for years, leading to disfigurement and sometimes skin cancer
Slide 7: M.Yousry TB&leprosy 7
Slide 8: M.Yousry TB&leprosy 8
Slide 9: M.Yousry TB&leprosy 9
Scrofuloderma : M.Yousry TB&leprosy 10 Scrofuloderma Results from direct extension of underlying TB infection of lymph nodes, bone or joints
Often associated with TB of the lungs
Firm, painless lesions that eventually ulcerate with a granular base
May heal even without treatment but this takes years and leaves unsightly scars
Miliary TB : M.Yousry TB&leprosy 11 Miliary TB Chronic TB infection that has spread from the primary infection (usually in the lungs) to other organs and tissues via the bloodstream
Skin lesions are small (millet-sized) red spots that develop into ulcers and abscesses
In immunocompromised patients, e.g. HIV, AIDS, cancer
The patient is generally sick
Prognosis is poor (many patients die even if diagnosed and treated)
TB cutis orificialis : M.Yousry TB&leprosy 12 TB cutis orificialis Results from autoinoculation of mycobacteria into the periorificial skin and mucous membranes in patients with advanced TB
Tuberculin sensitivity is strong. The site of the periorificial lesion often is determined by trauma.
Red papules that evolve into painful, soft, punched-out, shallow ulcers.
Tuberculid : M.Yousry TB&leprosy 13 Tuberculid Generalised exanthem in patients with moderate or high degree of immunity to TB
Usually in good health
Erythema induratum (Bazin disease) :recurring lumps on the back of the legs (mostly women) that may ulcerate and scar.
Papulonecrotic tuberculid :crops of recurrent crusted skin papules on knees, elbows, buttocks or lower trunk that heal with scarring after about 6 weeks.
Lichen scrofulosorum : an extending eruption of small follicular papules
T B Patient Work Up : M.Yousry TB&leprosy 14 T B Patient Work Up Medical history Perform a physical examination.
Tuberculin skin test
Posteroanterior chest radiograph
Specimens for bacteriologic examination: 3 sputum specimens on each of 3 consecutive days.
Skin biopsies
THERAPY of T B : M.Yousry TB&leprosy 15 THERAPY of T B Isoniazid: 5 mg/kg/d in adults; 10-20 mg/kg/d in children, not to exceed 300 mg qd
Rifampin: 10 mg/kg/d in adults; 10-20 mg/kg/d in children, not to exceed 600 mg qd
Pyrazinamide: 15-30 mg/kg/d in adults and children, not to exceed 2000 mg qd
Ethambutol: 15-25 mg/kg/d in adults and children or streptomycin: 15 mg/kg/d in adults; 20-40 mg/kg/d in children, not to exceed 1000 mg qd
Slide 16: M.Yousry TB&leprosy 16